To the Editor: Vitamin D deficiency is a significant risk factor for type 2 diabetes, although the effect of vitamin D supplementation for treatment of type 2 diabetes is still under debate [1][2][3]. It has also been reported that vitamin D receptor (VDR) is present in caveolae [4]. Dr Boucher has therefore posed two important questions [5] in response to our study [6] on caveolin-1 in an ageing-dependent nonobese type 2 diabetic animal model (JYD mouse): (1) whether insulin sensitivity could be improved by vitamin D in JYD mice; and (2) whether such an improvement might be due to an upregulation of caveolin-1 production affected by vitamin D.
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To answer Dr Boucher's first question, we measured glucose tolerance and insulin sensitivity in 30-week-old JYD mice treated with 1,25-dihydroxycholecalciferol [1,25(OH) 2 D 3 ], the hormonal form of vitamin D. Figure 1a shows that 1,25(OH) 2 D 3 -treated JYD mice had significantly improved glucose clearance compared with control mice, and 1,25(OH) 2 D 3 -treated mice had significantly lower glucose levels in response to insulin injection compared with control mice (Fig. 1b) ; this suggests that insulin sensitivity was improved. These results agree with previous reports that supplementation with 1,25(OH) 2 D 3 improves insulin sensitivity and glucose tolerance [7, 8] .
To answer Dr Boucher's second question, we performed western blot analysis on adipose tissue and skeletal muscle from 1,25(OH) 2 D 3 -treated JYD mice. We found that the level of caveolin-1, the principal component of caveolae, was not affected by 1,25(OH) 2 D 3 treatment in JYD mice (Fig. 2) , indicating that the positive effect of vitamin D on insulin sensitivity is affected via a mechanism other than caveolin-1 upregulation.
As it has been reported that Vdr mRNA expression is upregulated by 1,25(OH) 2 D 3 [9, 10], we studied the expression of Vdr mRNA in the skeletal muscle and adipose tissue of JYD mice treated with 1,25(OH) 2 D 3 and found that Vdr mRNA content in skeletal muscle, but not in adipose tissue, was upregulated by 1,25(OH) 2 D 3 treatment (Fig. 3) . Although some reports have shown that the tissue-specific regulation of VDR levels are influenced by the state of differentiation of the cells, serum parathyroid hormone level and extracellular calcium concentration [11] , the mechanisms for this tissue-specific upregulation of Vdr mRNA in JYD mice after 1,25(OH) 2 D 3 treatment remain to be determined. 1,25(OH) 2 D 3 exerts its actions by binding to VDR, which acts as a nuclear receptor or a cell surface receptor. The nuclear VDR is a ligand-dependent nuclear transcription factor and regulates the transcription of the target genes. The . Thus, the mechanism of action of vitamin D in the improvement of insulin resistance is mediated not only through regulation of signalling induction pathways by the cell surface VDR, but also through transcriptional regulation by nuclear VDR. Regardless of how insulin resistance is improved through VDR, our results suggest that 1,25(OH) 2 D 3 treatment may affect the insulin sensitivity of JYD mice by VDR upregulation in skeletal muscle tissues, but not by caveolin-1 status. We appreciate Dr Boucher's valuable comments on our work and we hope this letter answers some of the questions raised. were isolated. Total RNA was prepared using TRIzol reagents. a mRNA expression level of Vdr was determined by RT-PCR using a specific Vdr primer. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was the loading control. b The fold-change relative to the control band was quantitated by densitometric analysis. CON, black bar; VIT D, white bar. Each bar is the mean±SEM (n=4)
